Companies: 49,246 Total Market Cap: 132416288817079.32

Renata PLC

DSE-RENATA
Pharmaceutical Preparations
Rank #14325
Market Cap 450.37 M
Volume 5,603
Price 3.95
Change (%) 0.50%
Country or region Bangladesh Bangladesh

Renata PLC's latest marketcap:

450.37 M

As of 05/20/2025, Renata PLC's market capitalization has reached $450.37 M. According to our data, Renata PLC is the 14325th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 450.37 M
Revenue (ttm) 336.25 M
Net Income (ttm) 22.85 M
Shares Out 114.70 M
EPS (ttm) 0.20
Forward PE 22.17
Ex-Dividend Date 10/22/2024
Earnings Date 04/28/2025
Market Cap Chart
Data Updated: 05/20/2025

Renata PLC's yearly market capitalization.

Renata PLC has seen its market value drop from 107.87 B BDT to 55.44 B BDT since 2020, representing a total decrease of 48.60% and an annual compound decline rate (CAGR) of 14.07%.
Date Market Cap(BDT) Change (%)
05/20/2025 55.44 B -22.66%
12/30/2024 72.84 B -47.85%
12/27/2023 139.69 B 0%
12/29/2022 139.69 B -0.67%
12/30/2021 140.64 B 30.38%
12/30/2020 107.87 B

Company Profile

About Renata PLC

Renata PLC is a leading manufacturer, marketer, and distributor of pharmaceuticals, animal health products, and vaccines in Bangladesh. The company operates across multiple segments, including human healthcare, animal health, and consumer products.

Product Portfolio

Human Pharmaceuticals:

  • Antimicrobials, anti-hypertensive, and anti-diabetic medications
  • Cardiovascular, CNS, and hormone therapies
  • Anti-cancer, anti-asthma, and antiviral treatments
  • Vitamins, minerals, and nutritional supplements

Animal Health Products:

  • Antibiotics, antiparasitics, and antifungals
  • Poultry and aqua products
  • Live and killed vaccines
  • Nutritional premixes and metabolic products

Other Offerings:

  • Oncology-based products
  • Agro-based solutions
  • Consumer healthcare items

Company Background

Originally established as Pfizer Laboratories (Bangladesh) Limited in 1972, the company rebranded as Renata Limited in 1993. Headquartered in Dhaka, Renata PLC has grown into a key player in Bangladesh's pharmaceutical and healthcare industry.

Frequently Asked Questions

As of 05/20/2025, Renata PLC (including the parent company, if applicable) has an estimated market capitalization of $450.37 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Renata PLC global market capitalization ranking is approximately 14325 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Bangladesh
Founded 1972
IPO Date n/a
Employees 7,859
CEO Syed S. Kabir
Sector
Industry Pharmaceutical Preparations
Address Plot No. 1
Dhaka, 1216
Bangladesh
Website https://www.renata-ltd.com
People Also Watch
Ipsen S.A.
138.26 0.50%
Krka, d. d.
209.83 0.50%
BUD-RICHTER
29.12 0.50%
Hugel
245.27 0.50%